AKT1 and autosomal dominant polycystic kidney disease: Previous studies had suggested that treatment of an adult-onset ADPKD model with Alisertib resulted in exacerbation of cystic phenotypes32,33, an observation consistent with the increase in AURKA stability and AKT activation noted in vitro (Fig. 5f–i).